▶ 調査レポート

SPECT放射性医薬品の世界市場レポート2020

• 英文タイトル:Global SPECT Radiopharmaceuticals Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。SPECT放射性医薬品の世界市場レポート2020 / Global SPECT Radiopharmaceuticals Sales Market Report 2020 / QY20ST-04207資料のイメージです。• レポートコード:QY20ST-04207
• 出版社/出版日:QYResearch / 2020年9月25日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、135ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥560,000 (USD4,000)▷ お問い合わせ
  Multi User¥840,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,120,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界のSPECT放射性医薬品市場について種類別(テクネチウム-99、タリウム-201、ガリウム-67、ヨウ素-123、インジウム-111、その他)、用途別(腫瘍、循環器、甲状腺)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・SPECT放射性医薬品市場の概要
・世界の主要地域別SPECT放射性医薬品市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のSPECT放射性医薬品市場規模2015-2026:種類別(テクネチウム-99、タリウム-201、ガリウム-67、ヨウ素-123、インジウム-111、その他)
・世界のSPECT放射性医薬品市場規模2015-2026:用途別(腫瘍、循環器、甲状腺)
・SPECT放射性医薬品の北米市場規模2015-2020
・SPECT放射性医薬品のヨーロッパ市場規模2015-2020
・SPECT放射性医薬品の中国市場規模2015-2020
・SPECT放射性医薬品の日本市場規模2015-2020
・SPECT放射性医薬品の東南アジア市場規模2015-2020
・SPECT放射性医薬品のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・SPECT放射性医薬品の製造コスト分析
・販売チャネル、流通業者、顧客
・SPECT放射性医薬品の市場動向・機会・課題
・調査の結論

A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test that shows how blood flows to tissues and organs. Nuclear imaging requires small amounts of radioactive materials called radiopharmaceuticals – injected, inhaled or swallowed – to diagnose disease. SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, In-111,and other SPECT isotopes.

Market Analysis and Insights: Global SPECT Radiopharmaceuticals Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the SPECT Radiopharmaceuticals market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the SPECT Radiopharmaceuticals industry.
Based on our recent survey, we have several different scenarios about the SPECT Radiopharmaceuticals YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of SPECT Radiopharmaceuticals will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global SPECT Radiopharmaceuticals Scope and Market Size
The global SPECT Radiopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global SPECT Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the SPECT Radiopharmaceuticals market is segmented into
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other

Segment by Application, the SPECT Radiopharmaceuticals market is segmented into
Oncology
Cardiology
Thyroid

The SPECT Radiopharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the SPECT Radiopharmaceuticals market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and SPECT Radiopharmaceuticals Market Share Analysis
SPECT Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in SPECT Radiopharmaceuticals business, the date to enter into the SPECT Radiopharmaceuticals market, SPECT Radiopharmaceuticals product introduction, recent developments, etc.

The major vendors covered:
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences

レポート目次

1 SPECT Radiopharmaceuticals Market Overview
1.1 SPECT Radiopharmaceuticals Product Scope
1.2 SPECT Radiopharmaceuticals Segment by Type
1.2.1 Global SPECT Radiopharmaceuticals Sales by Type (2020-2026)
1.2.2 Technetium-99
1.2.3 Thallium-201
1.2.4 Gallium-67
1.2.5 Iodine-123
1.2.6 Indium-111
1.2.7 Other
1.3 SPECT Radiopharmaceuticals Segment by Application
1.3.1 Global SPECT Radiopharmaceuticals Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Thyroid
1.4 SPECT Radiopharmaceuticals Market Estimates and Forecasts (2015-2026)
1.4.1 Global SPECT Radiopharmaceuticals Sales Growth Rate (2015-2026)
1.4.2 Global SPECT Radiopharmaceuticals Revenue and Growth Rate (2015-2026)
1.4.3 Global SPECT Radiopharmaceuticals Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): SPECT Radiopharmaceuticals Industry Impact
1.5.1 How the Covid-19 is Affecting the SPECT Radiopharmaceuticals Industry
1.5.1.1 SPECT Radiopharmaceuticals Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and SPECT Radiopharmaceuticals Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for SPECT Radiopharmaceuticals Players to Combat Covid-19 Impact

2 SPECT Radiopharmaceuticals Estimate and Forecast by Region
2.1 Global SPECT Radiopharmaceuticals Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global SPECT Radiopharmaceuticals Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global SPECT Radiopharmaceuticals Sales Market Share by Region (2015-2020)
2.2.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
2.3 Global SPECT Radiopharmaceuticals Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global SPECT Radiopharmaceuticals Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States SPECT Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.2 Europe SPECT Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.3 China SPECT Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.4 Japan SPECT Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.5 Southeast Asia SPECT Radiopharmaceuticals Estimates and Projections (2015-2026)
2.4.6 India SPECT Radiopharmaceuticals Estimates and Projections (2015-2026)
3 Global SPECT Radiopharmaceuticals Competition Landscape by Players
3.1 Global Top SPECT Radiopharmaceuticals Players by Sales (2015-2020)
3.2 Global Top SPECT Radiopharmaceuticals Players by Revenue (2015-2020)
3.3 Global SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SPECT Radiopharmaceuticals as of 2019)
3.4 Global SPECT Radiopharmaceuticals Average Price by Company (2015-2020)
3.5 Manufacturers SPECT Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key SPECT Radiopharmaceuticals Players (Opinion Leaders)
4 Global SPECT Radiopharmaceuticals Market Size by Type
4.1 Global SPECT Radiopharmaceuticals Historic Market Review by Type (2015-2020)
4.1.1 Global SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.1.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
4.1.3 Global SPECT Radiopharmaceuticals Price by Type (2014-2020)
4.2 Global SPECT Radiopharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global SPECT Radiopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 Global SPECT Radiopharmaceuticals Price Forecast by Type (2021-2026)
5 Global SPECT Radiopharmaceuticals Market Size by Application
5.1 Global SPECT Radiopharmaceuticals Historic Market Review by Application (2015-2020)
5.1.1 Global SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
5.1.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
5.1.3 Global SPECT Radiopharmaceuticals Price by Application (2015-2020)
5.2 Global SPECT Radiopharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global SPECT Radiopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global SPECT Radiopharmaceuticals Price Forecast by Application (2021-2026)

3 North America SPECT Radiopharmaceuticals Market Facts & Figures
3.2 North America SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
3.3 North America SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
3.4 North America SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)

4 Europe SPECT Radiopharmaceuticals Market Facts & Figures
4.2 Europe SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
4.3 Europe SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.4 Europe SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)

5 China SPECT Radiopharmaceuticals Market Facts & Figures
5.2 China SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
5.3 China SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
5.4 China SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)

6 Japan SPECT Radiopharmaceuticals Market Facts & Figures
6.2 Japan SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
6.3 Japan SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
6.4 Japan SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)

7 Southeast Asia SPECT Radiopharmaceuticals Market Facts & Figures
7.2 Southeast Asia SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
7.3 Southeast Asia SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
7.4 Southeast Asia SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)

8 India SPECT Radiopharmaceuticals Market Facts & Figures
8.2 India SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
8.3 India SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
8.4 India SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in SPECT Radiopharmaceuticals Business
12.1 GE Healthcare
12.1.1 GE Healthcare SPECT Radiopharmaceuticals Corporation Information
12.1.2 GE Healthcare SPECT Radiopharmaceuticals Business Overview and Total Revenue
12.1.3 GE Healthcare SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GE Healthcare SPECT Radiopharmaceuticals Products Offered
12.1.5 GE Healthcare Recent Development
12.2 Cardinal Health
12.2.1 Cardinal Health SPECT Radiopharmaceuticals Corporation Information
12.2.2 Cardinal Health SPECT Radiopharmaceuticals Business Overview and Total Revenue
12.2.3 Cardinal Health SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cardinal Health SPECT Radiopharmaceuticals Products Offered
12.2.5 Cardinal Health Recent Development
12.3 Lantheus Medical Imaging
12.3.1 Lantheus Medical Imaging SPECT Radiopharmaceuticals Corporation Information
12.3.2 Lantheus Medical Imaging SPECT Radiopharmaceuticals Business Overview and Total Revenue
12.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Products Offered
12.3.5 Lantheus Medical Imaging Recent Development
12.4 Bracco Imaging
12.4.1 Bracco Imaging SPECT Radiopharmaceuticals Corporation Information
12.4.2 Bracco Imaging SPECT Radiopharmaceuticals Business Overview and Total Revenue
12.4.3 Bracco Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bracco Imaging SPECT Radiopharmaceuticals Products Offered
12.4.5 Bracco Imaging Recent Development
12.5 Eczacibasi-Monrol Nuclear Products
12.5.1 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Corporation Information
12.5.2 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Business Overview and Total Revenue
12.5.3 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Products Offered
12.5.5 Eczacibasi-Monrol Nuclear Products Recent Development
12.6 IBA Molecular Imaging
12.6.1 IBA Molecular Imaging SPECT Radiopharmaceuticals Corporation Information
12.6.2 IBA Molecular Imaging SPECT Radiopharmaceuticals Business Overview and Total Revenue
12.6.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.6.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Products Offered
12.6.5 IBA Molecular Imaging Recent Development
12.7 Jubilant Life Sciences
12.7.1 Jubilant Life Sciences SPECT Radiopharmaceuticals Corporation Information
12.7.2 Jubilant Life Sciences SPECT Radiopharmaceuticals Business Overview and Total Revenue
12.7.3 Jubilant Life Sciences SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Jubilant Life Sciences SPECT Radiopharmaceuticals Products Offered
12.7.5 Jubilant Life Sciences Recent Development

13 SPECT Radiopharmaceuticals Manufacturing Cost Analysis
13.1 SPECT Radiopharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of SPECT Radiopharmaceuticals
13.4 SPECT Radiopharmaceuticals Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 SPECT Radiopharmaceuticals Distributors List
14.3 SPECT Radiopharmaceuticals Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global SPECT Radiopharmaceuticals Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global SPECT Radiopharmaceuticals Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four SPECT Radiopharmaceuticals Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for SPECT Radiopharmaceuticals Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for SPECT Radiopharmaceuticals Players to Combat Covid-19 Impact
Table 8. Global Market SPECT Radiopharmaceuticals Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global SPECT Radiopharmaceuticals Sales (K Units) by Region (2015-2020)
Table 10. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 11. Global SPECT Radiopharmaceuticals Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global SPECT Radiopharmaceuticals Revenue Share by Region (2015-2020)
Table 13. Global SPECT Radiopharmaceuticals Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global SPECT Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 15. Global SPECT Radiopharmaceuticals Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global SPECT Radiopharmaceuticals Revenue Share Forecast by Region (2021-2026)
Table 17. Global SPECT Radiopharmaceuticals (K Units) of Key Companies (2015-2020)
Table 18. Global SPECT Radiopharmaceuticals Sales Share by Company (2015-2020)
Table 19. Global SPECT Radiopharmaceuticals Revenue (US$ Million) by Company (2015-2020)
Table 20. Global SPECT Radiopharmaceuticals Revenue Share by Company (2015-2020)
Table 21. Global SPECT Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SPECT Radiopharmaceuticals as of 2019)
Table 22. Global SPECT Radiopharmaceuticals Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers SPECT Radiopharmaceuticals Manufacturing Sites and Area Served
Table 24. Manufacturers SPECT Radiopharmaceuticals Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key SPECT Radiopharmaceuticals Players
Table 27. Global SPECT Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 28. Global SPECT Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 29. Global SPECT Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global SPECT Radiopharmaceuticals Price (K Units) by Type (2015-2020)
Table 31. Global SPECT Radiopharmaceuticals Sales Share by Type (2021-2026)
Table 32. Global SPECT Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global SPECT Radiopharmaceuticals Revenue Share by Type (2021-2026)
Table 34. Global SPECT Radiopharmaceuticals Price (K Units) by Type (2021-2026)
Table 35. Global SPECT Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 36. Global SPECT Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 37. Global SPECT Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global SPECT Radiopharmaceuticals Price (K Units) by Application (2015-2020)
Table 39. Global SPECT Radiopharmaceuticals Sales (K Units) by Application (2021-2026)
Table 40. Global SPECT Radiopharmaceuticals Sales Share by Application (2021-2026)
Table 41. Global SPECT Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global SPECT Radiopharmaceuticals Revenue Share by Application (2021-2026)
Table 43. Global SPECT Radiopharmaceuticals Price (K Units) by Application (2021-2026)
Table 44. United States SPECT Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 45. United States SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 46. United States SPECT Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 47. United States SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 48. United States SPECT Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 49. United States SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 50. Europe SPECT Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 51. Europe SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 52. Europe SPECT Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 53. Europe SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 54. Europe SPECT Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 55. Europe SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 56. China SPECT Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 57. China SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 58. China SPECT Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 59. China SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 60. China SPECT Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 61. China SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 62. Japan SPECT Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 63. Japan SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 64. Japan SPECT Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 65. Japan SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 66. Japan SPECT Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 67. Japan SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia SPECT Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia SPECT Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia SPECT Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 74. India SPECT Radiopharmaceuticals Sales (K Units) by Company (2015-2020)
Table 75. India SPECT Radiopharmaceuticals Sales Market Share by Company (2015-2020)
Table 76. India SPECT Radiopharmaceuticals Sales (K Units) by Type (2015-2020)
Table 77. India SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 78. India SPECT Radiopharmaceuticals Sales (K Units) by Application (2015-2020)
Table 79. India SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 80. GE Healthcare Corporation Information
Table 81. GE Healthcare Description and Business Overview
Table 82. GE Healthcare SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GE Healthcare SPECT Radiopharmaceuticals Product
Table 84. GE Healthcare Recent Development
Table 85. Cardinal Health Corporation Information
Table 86. Cardinal Health Description and Business Overview
Table 87. Cardinal Health SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Cardinal Health SPECT Radiopharmaceuticals Product
Table 89. Cardinal Health Recent Development
Table 90. Lantheus Medical Imaging Corporation Information
Table 91. Lantheus Medical Imaging Description and Business Overview
Table 92. Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Lantheus Medical Imaging SPECT Radiopharmaceuticals Product
Table 94. Lantheus Medical Imaging Recent Development
Table 95. Bracco Imaging Corporation Information
Table 96. Bracco Imaging Description and Business Overview
Table 97. Bracco Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bracco Imaging SPECT Radiopharmaceuticals Product
Table 99. Bracco Imaging Recent Development
Table 100. Eczacibasi-Monrol Nuclear Products Corporation Information
Table 101. Eczacibasi-Monrol Nuclear Products Description and Business Overview
Table 102. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Product
Table 104. Eczacibasi-Monrol Nuclear Products Recent Development
Table 105. IBA Molecular Imaging Corporation Information
Table 106. IBA Molecular Imaging Description and Business Overview
Table 107. IBA Molecular Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. IBA Molecular Imaging SPECT Radiopharmaceuticals Product
Table 109. IBA Molecular Imaging Recent Development
Table . Jubilant Life Sciences Corporation Information
Table . Jubilant Life Sciences Description and Business Overview
Table . Jubilant Life Sciences SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Jubilant Life Sciences SPECT Radiopharmaceuticals Product
Table . Jubilant Life Sciences Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. SPECT Radiopharmaceuticals Distributors List
Table 118. SPECT Radiopharmaceuticals Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. SPECT Radiopharmaceuticals Product Picture
Figure 2. Global SPECT Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global SPECT Radiopharmaceuticals Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Cardiology Examples
Figure 8. Thyroid Examples
Figure 9. Global SPECT Radiopharmaceuticals Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global SPECT Radiopharmaceuticals Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global SPECT Radiopharmaceuticals Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global SPECT Radiopharmaceuticals Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global SPECT Radiopharmaceuticals Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States SPECT Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States SPECT Radiopharmaceuticals Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe SPECT Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe SPECT Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China SPECT Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China SPECT Radiopharmaceuticals Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan SPECT Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan SPECT Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia SPECT Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia SPECT Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India SPECT Radiopharmaceuticals Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India SPECT Radiopharmaceuticals Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest SPECT Radiopharmaceuticals Players Market Share by Revenue in SPECT Radiopharmaceuticals 2015 & 2019
Figure 27. SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global SPECT Radiopharmaceuticals Revenue Share by Type (2015-2020)
Figure 29. Global SPECT Radiopharmaceuticals Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global SPECT Radiopharmaceuticals Revenue Share by Application (2015-2020)
Figure 31. Global SPECT Radiopharmaceuticals Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States SPECT Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 33. United States SPECT Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 34. Europe SPECT Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 35. Europe SPECT Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 36. Europe SPECT Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 37. China SPECT Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 38. China SPECT Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 39. China SPECT Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 40. Japan SPECT Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 41. Japan SPECT Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 42. Japan SPECT Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 43. Southeast Asia SPECT Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 44. Southeast Asia SPECT Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 45. Southeast Asia SPECT Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 46. India SPECT Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 47. India SPECT Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 48. India SPECT Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 49. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Lantheus Medical Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Eczacibasi-Monrol Nuclear Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. IBA Molecular Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Jubilant Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of SPECT Radiopharmaceuticals
Figure 58. Manufacturing Process Analysis of SPECT Radiopharmaceuticals
Figure 59. SPECT Radiopharmaceuticals Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed